WebMDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients. WebThe formula for FIB-4 is: Age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). The AUROC of the index was 0.765 for differentiation between Ishak stage 0-3 and 4-6. At a …
磁共振弹性成像测得肝弹力值、脾弹力值对门静脉高压的诊断效能_ …
WebFIB-4 = Age (years) x AST Level (U/L) Platelet Count (109/L) x √ ALT (U/L) = Interpretation: Using a lower cutoff value of 1.45, a FIB-4 score <1.45 had a negative predictive value of 90% for advanced fibrosis (Ishak fibrosis score 4-6 which includes early … WebDetermine FIB-4, NFS, and APRI scores using the calculators below. You can calculate any one of three simple scores to assess the presence of Advanced Fibrosis. NIT Calculators * Choose which score you would like to calculate, then fill in the required information. FIB-4 NFS Calculator is provided for educational and illustrative purposes only. thelismond belende
APRI and FIB-4 performance to assess liver fibrosis against ... - LWW
WebMDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients. WebFIB-4 Calculator Fibrosis-4 (FIB-4) Calculator; Glasgow Coma Scale Glasgow Coma Scale; GFR Calculator Glomerular Filtration Rate (GFR) Estimate by MDRD 4-Variable Equation; MELD Calculator Model for End-Stage Liver Disease (MELD) for ages 12 and older; SAAG Calculator Serum-Ascites Albumin Gradient (SAAG) WebThe Fibrosis 4 (FIB-4) Score (available at www.gihep.com/calculators/hepatology/fibrosis-4-score/) which uses the person's age, AST, ALT, and platelet count, and which has been developed to assess the risk of cirrhosis in people with hepatitis C and non-alcoholic steatohepatitis (NASH) [ Dyson et al, 2014 ]. Basis for recommendation the lisle no. 404090